That is 0 articles you have read today.
The Aporia is free and carries no advertising, so readers are the only
thing paying for it. If you are getting this much out of it, a small
donation is what keeps it independent.
Daily limit reached
You have read 0 articles today.
That is more than the 15 a day The Aporia gives away,
and well past what it can carry on nothing. Your allowance resets at
midnight.
There is no advertising here and nothing about you is sold, so readers
are the only thing paying for it. If the site is worth this much of
your day, it is worth a few dollars.
Everything else stays open: the
maps, the
directory and
search do
not count against this, and neither does re-opening something you have
already read today.
Russia is cutting its federal cancer programme budget from 44.9 billion to 3.87 billion roubles for 2027, a nearly forty-fold reduction compared to 2025 levels, as defence spending reaches an all-time high of 35% since the Soviet Union's collapse. This drastic reduction in health funding is coupled with a growing trend of Russian cancer patients bearing more out-of-pocket costs; a study found that between 2019 and 2025, patient purchases of essential medicines rose by nearly one million packs to 5.8 million due to supply disruptions and regional budget shortfalls.
Written locally by qwen2.5:14b on 2026-10-09,
using this article's own text rather than the other coverage of the
same event (that is the story summary below).
Story summary
In 2027, Russia will cut funding for welfare, education, and healthcare by significant percentages as it increases military spending to unprecedented levels. The country plans to spend 17.1 trillion roubles ($202.58 billion) on defense in 2027 alone, a 27% increase from the original budget of 13.5 trillion roubles, making it the highest military spending since Russia's invasion of Ukraine began in 2022. Welfare funding will shrink by 7%, education by 6%, and healthcare by 6.8%. Additionally, Russia's federal cancer program budget is being slashed from 44.9 billion roubles to just 3.87 billion roubles, a nearly 12-fold reduction. These cuts reflect the strain of war on Russian finances, forcing Moscow to tap into fiscal reserves, increase borrowing, and raise taxes to fund its expanding military expenditure while prioritizing defense over social programs.
Written for “Russia War Spending” on 2026-10-09,
grounded in this article and the 5 other(s) covering the same event.
Why this leaning score
The article's own words the score was based on. Each is quoted
verbatim and was checked against the article text before being
stored, so you can find it in the original.
-
The federal cancer programme budget falls from 44.9 billion to 3.87 billion roubles in 2027 — a nearly 40-fold reduction against 2025 levels — as defence spending reaches 35% of all federal expenditure, the highest share since the Soviet Union collapsed.
left Highlights the drastic cut to healthcare funding while emphasizing increased military spending.
-
Funding is projected to recover partially thereafter — rising to 5.76 billion roubles in 2028 and 12.78 billion in 2029 — but both figures remain far below current levels.
left Emphasizes the long-term underfunding of healthcare compared to previous years.
-
Under the new 2027-2029 budget, the remaining money is expected to go mainly to diagnostic and radiology equipment, while specialised units in smaller towns and rural areas face cuts, a distribution likely to deepen an already significant gap between cancer care in major federal centres and outlying regions.
left Highlights the unequal distribution of healthcare resources due to budget cuts.
-
Patient organisations and some experts have questioned whether the new mechanisms could fully offset the federal reduction, and noted that shifting costs to regional budgets and the OMS ties the quality of care more directly to the financial strength of individual regions.
left Critiques the proposed cost-shifting measures as inadequate.
-
A study by the NGO Movement Against Cancer found that between 2019 and 2025, patients bought roughly one in every six or seven packs of cancer medicines out of pocket.
left Draws attention to the financial burden on patients due to inadequate healthcare funding.
Leaning: leans strongly left for article 67604 (high confidence, 5 verified quotes) · logged 2026-10-09
The federal cancer programme budget falls from 44.9 billion to 3.87 billion roubles in 2027 — a nearly 40-fold reduction against 2025 levels — as defence spending reaches 35% of all federal expenditure, the highest share since the Soviet Union collapsed.
asserted
Union → fall → expenditure
Russia is cutting funding for its national cancer programme nearly twelvefold in 2027, from 44.9 billion roubles (€470.5m) to 3.87 billion roubles (€40.5m), according to the draft federal budget, as defence spending reaches its highest share since the collapse of the Soviet Union.
uncertain
spending → cut → Union
The reduction is even sharper compared to last year: the programme received 148.5 billion roubles (€1.5bn) in 2025, meaning federal spending on cancer control would have fallen roughly 38-fold in two years if the budget passes as proposed.
asserted
budget → compare → years
Funding is projected to recover partially thereafter — rising to 5.76 billion roubles in 2028 and 12.78 billion in 2029 — but both figures remain far below current levels.
Since its launch, the federal cancer project has funded diagnostic equipment, cancer centres, and early screening programmes.
asserted
project → project → equipment
Under the new 2027-2029 budget, the remaining money is expected to go mainly to diagnostic and radiology equipment, while specialised units in smaller towns and rural areas face cuts, a distribution likely to deepen an already significant gap between cancer care in major federal centres and outlying regions.
asserted
units → remain → centres
Rerouting roubles
Officials have said some costs will be transferred to the compulsory health insurance system (OMS) and other budget lines rather than eliminated entirely.
asserted
costs → reroute → system
Patient organisations and some experts have questioned whether the new mechanisms could fully offset the federal reduction, and noted that shifting costs to regional budgets and the OMS ties the quality of care more directly to the financial strength of individual regions.
The proposed cuts come as new data show Russian cancer patients are already bearing a growing share of treatment costs.
uncertain
patients → question → costs
A study by the NGO Movement Against Cancer found that between 2019 and 2025, patients bought roughly one in every six or seven packs of cancer medicines out of pocket.
asserted
patients → find → pocket
In 2025 alone, household spending on anti-tumour drugs rose from 8.8 billion to 11.4 billion roubles, and the number of packs bought independently increased from five million to 5.8 million.
asserted
number → rise → million
Around 94% of those drugs are on the list of essential medicines and should be provided free of charge.
asserted
% → provide → charge
The study's authors attribute the out-of-pocket spending not to patients choosing more expensive options — most purchases involved generics — but to supply disruptions and gaps in provision.
asserted
purchases → attribute → provision
Russian law guarantees cancer patients free access to the medicines they need, but in practice, patients and doctors have long reported procurement delays and regional budget shortfalls.
asserted
patients → guarantee → delays
State procurement remains substantial: official figures show the government bought 32.8 million packs of medicines worth 336 billion roubles through the OMS system in 2025.
asserted
government → remain → 2025
But the trajectory in out-of-pocket spending suggests the burden on patients is already rising ahead of the planned federal cuts.
uncertain
burden → suggest → cuts
Defence spending in the 2027 draft budget is set to reach 17.1 trillion roubles, or roughly 35% of all federal expenditure — a post-Soviet record.
asserted
spending → set → expenditure
More than four years of Moscow's all-out war in Ukraine have progressively shifted Russia's public spending, with civilian programmes including healthcare and medical infrastructure taking a backseat to continued expansion of defence outlays.
asserted
programmes → shift → outlays
The Aporia
